Bergen 15 June 2023: Reference is made to previous stock exchange announcements
published by BerGenBio ASA (the "Company"), regarding the partially underwritten
rights issue of between 1,687,500,000 and 2,500,000,000 new shares in the
Company (the "Offer Shares") at a subscription price of NOK 0.10 per Offer Share
(the "Rights Issue"). In addition, the subscribers in the Rights Issue will be
allocated one warrant for every two Offer Shares allocated to them and paid by
them in the Rights Issue (the "Warrants"). Reference is further made to the
mandatory notifications of trade on 7 June, 8 June and 13 June 2023. Following
the allocation of Offer Shares and Warrants on 14 June 2023, the following Offer
Shares and Warrants have been allocated to primary insiders and their close
associates:
Nigel McCracken, CSO of the Company, subscribed for 550,000 Offer Shares in the
Rights Issue. McCracken was allocated 285,108 Offer Shares at a price of NOK
0.10 per share and 142 554 Warrants. Following delivery of the Offer Shares,
McCracken's total ownership in the Company amounts to 285,108 shares.
James Barnes, COO of the Company, subscribed for 500,000 Offer Shares in the
Rights Issue. Barnes was allocated 259,190 Offer Shares at a price of NOK 0.10
per share and 129,595 Warrants. Following delivery of the Offer Shares, Barnes's
total ownership in the Company amounts to 259,190 shares.
Martin Olin, CEO of the Company, subscribed for 2,000,000 Offer Shares in the
Rights Issue. Olin was allocated 2,000,000 Offer Shares at a price of NOK 0.10
per share and 1,000,000 Warrants. Following delivery of the Offer Shares, Olin's
total ownership in the Company amounts to 2,037,100 shares.
Rune Skeie, CFO of the Company, subscribed for 500,000 Offer Shares in the
Rights Issue. Skeie was allocated 259,190 Offer Shares at a price of NOK 0.10
per share and 129,595 Warrants. Following delivery of the Offer Shares, Skeie's
total ownership in the Company amounts to 259,190 shares.
Anders Tullgren, Chairman of the Board of the Company, subscribed for 1,409,820
Offer Shares in the Rights Issue. Tullgren was allocated 1,409,820 Offer Shares
at a price of NOK 0.10 per share and 704,910 Warrants. Following delivery of the
Offer Shares, Tullgren's total ownership in the Company amounts to 1,459,820
shares.
Svev AS, a company closely associated with and 100% owned by Sveinung Hole,
Board member of the Company, subscribed for 2,000,000 Offer Shares in the Rights
Issue. Svev AS was allocated 2,000,000 Offer Shares at a price of NOK 0.10 per
share and 1,000,000 Warrants. Following delivery of the Offer Shares, Svev's
total ownership in the Company amounts to 2,000,000 shares.
Sally Bennett, Board member of the Company, subscribed for 607,320 Offer Shares
in the Rights Issue. Bennett was allocated 314,826 Shares at a price of NOK 0.10
per share and 157,413 Warrants. Following delivery of the Offer Shares,
Bennett's total ownership in the Company amounts to 314,826 shares.
Debra Barker, Board member of the Company, subscribed for 600,000 Offer Shares
in the Rights Issue. Barker was allocated 311,027 Shares at a price of NOK 0.10
per share and 155,513 Warrants. Following delivery of the Offer Shares, Barker's
total ownership in the Company amounts to 311,027 shares.
Sarsia Develoment AS, a company closely associated with Sveinung Hole, Board
member of the Company, subscribed for 33,500,000 Offer Shares in the Rights
Issue. Sarsia Develoment AS was allocated 33,500,000 Offer Shares at a price of
NOK 0.10 per share and 16,750,000 Warrants. Following delivery of the Offer
Shares, Sarsia Developmen's total ownership in the Company amounts to 33,675,000
shares.
Sarsia Seed AS, a company closely associated with Sveinung Hole, Board member of
the Company, subscribed for 8,100,000 Offer Shares in the Rights Issue. Sarsia
Seed AS was allocated 8,100,000 Offer Shares at a price of NOK 0.10 per share
and 4,050,000 Warrants. Following delivery of the Offer Shares, Sarsia Seed's
total ownership in the Company amounts to 8,100,000 shares.
Please see further details about the transactions in the attached forms.
This information is subject to the disclosure requirements pursuant to article
19 of the EU Market Abuse Regulation and section 5-12 of the Norwegian
Securities Trading Act.